Drug used by ISIS fighter to suppress pain, fatigue seized by DRI

Image
Press Trust of India Mumbai
Last Updated : May 29 2018 | 6:55 PM IST

In a major catch, the Directorate of Revenue Intelligence (DRI) has seized over 2.5 tonnes Tramadol tablets, containing psychotropic substance, used by ISIS terrorists to suppress pain and to overcome fatigue, from a factory in Palghar near here.

Tramadol, a painkiller, is abused all over the world by drug addicts.

It is used as an opioid mainly by terrorists of ISIS to suppress pain and fatigue, official sources said.

These seized tablets were meant for illegal export to the Middle East and some other countries, they said.

India recently brought the drug within the ambit of the Narcotic Drugs & Psychotropic Substances (NDPS) Act, 1985, making its production and sale without the approval of the Central Bureau of Narcotics, Gwalior, illegal.

Acting on intelligence, searches conducted yesterday by the DRI officials at the factory premises resulted in the recovery of Tramadol tablets and Tramadol powder, worth several crores of rupees in international drug market, an official statement issued today said.

Further searches conducted at a warehouse situated at Dronagiri, Raigad district, resulted in the recovery of 959 cartons containing 4,48,68,000 Tramadol tablets.

Thus, Tramadol tablets totally numbering 6,11,48,000 (2,708 kg or 2.7 tonnes) and 56.4 kgs Tramadol in powder form, which were manufactured and attempted to be cleared by the drug syndicate, were seized, it said.

The seized narcotics are worth at least Rs 50 crore in the international market.

The director of the factory and a chemist have admitted to their roles in the illegal manufacture of psychotropic substance in large quantity on behalf of a merchant exporter based in Haryana and were arrested, the DRI said in the statement.

Besides, a middleman, who had placed orders for such a huge quantity on behalf of the exporters and had paid him advance for procurement of raw materials, was also arrested, it said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 29 2018 | 6:55 PM IST

Next Story